Dr. Markus Lang

Development Strategy & Operations

Dr. Markus Lang will help us:

• Further develop our nanoparticle technology.

• Oversee platform optimization, including formulation and manufacturability.

• Plans and evaluate preclinical studies.

Biosketch

Dr. Markus Lang supports our team with his extensive experience in project management within the pharmaceutical industry, having spent many years in leading positions at Boehringer Ingelheim, Fresenius and MorphoSys AG. He is well-versed in regulatory requirements and brings significant expertise in organizing both preclinical and clinical development. Dr. Lang has played a key role in four oncological projects that successfully resulted in market approval. Once the fundraising has been completed, he will take on an active role at NanoDrug Delivery GmbH.